Works matching IS 02614189 AND DT 2019 AND VI 38 AND IP 20


Results: 12
    1
    2

    Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses.

    Published in:
    EMBO Journal, 2019, v. 38, n. 20, p. N.PAG, doi. 10.15252/embj.2019102096
    By:
    • Timofeev, Oleg;
    • Klimovich, Boris;
    • Schneikert, Jean;
    • Wanzel, Michael;
    • Pavlakis, Evangelos;
    • Noll, Julia;
    • Mutlu, Samet;
    • Elmshäuser, Sabrina;
    • Nist, Andrea;
    • Mernberger, Marco;
    • Lamp, Boris;
    • Wenig, Ulrich;
    • Brobeil, Alexander;
    • Gattenlöhner, Stefan;
    • Köhler, Kernt;
    • Stiewe, Thorsten
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Prdx4 limits caspase‐1 activation and restricts inflammasome‐mediated signaling by extracellular vesicles.

    Published in:
    EMBO Journal, 2019, v. 38, n. 20, p. 1, doi. 10.15252/embj.2018101266
    By:
    • Lipinski, Simone;
    • Pfeuffer, Steffen;
    • Arnold, Philipp;
    • Treitz, Christian;
    • Aden, Konrad;
    • Ebsen, Henriette;
    • Falk‐Paulsen, Maren;
    • Gisch, Nicolas;
    • Fazio, Antonella;
    • Kuiper, Jan;
    • Luzius, Anne;
    • Billmann‐Born, Susanne;
    • Schreiber, Stefan;
    • Nuñez, Gabriel;
    • Beer, Hans‐Dietmar;
    • Strowig, Till;
    • Lamkanfi, Mohamed;
    • Tholey, Andreas;
    • Rosenstiel, Philip
    Publication type:
    Article
    10
    11
    12